Abstract 2850: PHI-501, a novel pan-RAF inhibitor, enhances immunotherapy efficacy by converting cold tumors into hot tumors
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Yonsei University, Yonsei Cancer Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148769251
Cites:
Cited by:
Related to:
